Drug Type Bispecific killer cell engager (BiKE) |
Synonyms C-7 biVHH |
Target |
Mechanism CD16a agonists(Low affinity immunoglobulin gamma Fc region receptor III-A agonists), EGFR modulators(Epidermal growth factor receptor erbB1 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colorectal Cancer | Discovery | NL | - | |
Colorectal Cancer | Discovery | NL | - | |
Colorectal Cancer | Discovery | NL | - | |
Colorectal Cancer | Discovery | NL | - |